Immobilized Trypsin Market

Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.

Immobilized Trypsin Market contains market size and forecasts of Immobilized Trypsin in global, including the following market information:

Global Immobilized Trypsin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Immobilized Trypsin Market Sales, 2017-2022, 2023-2028, (K Unit)

Global top five Immobilized Trypsin companies in 2021 (%)

The global Immobilized Trypsin market was valued at 10 million in 2021 and is projected to reach US$ 15 million by 2028, at a CAGR of 5.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2 ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immobilized Trypsin include Promega, Thermo Scientific, G-Biosciences, SignalChem, Takara, GoldBio, Creative Enzymes and ProteoChem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Immobilized Trypsin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immobilized Trypsin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Immobilized Trypsin Market Segment Percentages, by Type, 2021 (%)

2 ml

4 ml

Others

Global Immobilized Trypsin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Immobilized Trypsin Market Segment Percentages, by Application, 2021 (%)

Academic & Research Institutes

Pharmaceutical Companies

Global Immobilized Trypsin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Immobilized Trypsin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immobilized Trypsin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immobilized Trypsin revenues share in global market, 2021 (%)

Key companies Immobilized Trypsin sales in global market, 2017-2022 (Estimated), (K Unit)

Key companies Immobilized Trypsin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Promega

Thermo Scientific

G-Biosciences

SignalChem

Takara

GoldBio

Creative Enzymes

ProteoChem